Related Experiment Video
Updated: Jul 10, 2026

Semi-Quantitative Analysis of Peptidoglycan by Liquid Chromatography Mass Spectrometry and Bioinformatics
Published on: October 13, 2020
Analysis of peptide mimotopes of Burkholderia pseudomallei exopolysaccharide
Joseph B Legutki1, Michelle Nelson, Richard Titball
1Department of Microbiology, The Ohio State University, 484 W 12th Ave Rm 376, Columbus, OH 43210, United States. Bart.Legutki@asu.edu
Abstract:
Previously two capsule-specific monoclonal antibodies (4VA5 and 3VIE5) were identified as protective against Burkholderia pseudomallei in passive transfer experiments. Panning these antibodies against evolutionary phage libraries identified reactive peptides capable of inhibiting its parent monoclonal from binding to B. pseudomallei. Mice immunized with peptide conjugated to thyroglobulin developed serum antibodies capable of recognizing the immunizing peptide of which a subset recognized exopolysaccharide in the context of whole B. pseudomallei cells. These serum antibodies recognized protease treated B. pseudomallei but not B. thailandensis suggesting that these peptides are mimotopes of the B. pseudomallei capsular exopolysaccharide. In a murine model of acute melioidosis, immunization with the mimotope of the 4VA5 binding site extended the mean time to death to 8.00 days over the 2.18 days afforded by immunization with thyroglobulin alone. This mimotope may be of use in developing an antibody response against B. pseudomallei exopolysaccharide.
Insights
Researchers developed mimotopes that mimic Burkholderia pseudomallei’s exopolysaccharide. Immunizing mice with these mimotopes improved survival in a melioidosis model, suggesting potential for a B. pseudomallei vaccine.
Area of Science:
- Microbiology
- Immunology
- Vaccine Development
Background:
- Monoclonal antibodies 4VA5 and 3VIE5 demonstrated protection against Burkholderia pseudomallei.
- Phage library panning identified peptides that inhibit antibody binding to B. pseudomallei.
Purpose of the Study:
- To develop mimotopes of B. pseudomallei's capsular exopolysaccharide.
- To evaluate the immunogenicity and protective efficacy of these mimotopes.
Main Methods:
- Phage display panning to identify antibody-reactive peptides.
- Conjugation of peptides to thyroglobulin for immunization.
- Assessment of serum antibody recognition of peptides and B. pseudomallei.
- Evaluation of immunization efficacy in a murine model of acute melioidosis.
Main Results:
- Identified peptides that act as mimotopes of B. pseudomallei exopolysaccharide.
- Immunization with a mimotope (4VA5 binding site) extended mean survival time in mice from 2.18 to 8.00 days.
- Resulting antibodies recognized B. pseudomallei exopolysaccharide.
Conclusions:
- Peptide mimotopes can elicit immune responses targeting B. pseudomallei exopolysaccharide.
- This mimotope strategy shows promise for developing subunit vaccines against B. pseudomallei.
- Further development could lead to novel strategies for combating melioidosis.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Peptidoglycan Synthesis
